Although the effects of broussonin A and B on integrin functions including ligand binding and signalling networks remain to be further determined, treatment with broussonin A or B markedly suppresses VEGF‐A‐ and mitogen‐induced expression of integrin β1 in endothelial cells and cancer cells, respectively. The gene discussed is VEGFA; the disease is cancer.